John Curran
Ceist:328. Deputy John Curran asked the Minister for Health if regulations to allow for the introduction of buprenorphine naloxone and buprenorphine products have been agreed and introduced. [52691/18]
Amharc ar fhreagraTuesday, 18 December 2018
Ceisteanna (328)
Freagraí scríofa
On 22 November 2017, I signed the Misuse of Drugs (Supervision of Prescription and Supply of Methadone and Medicinal Products containing Buprenorphine authorised for Opioid Substitution Treatment) Regulations 2017 (S.I. No. 522 of 2017). The Regulations added certain buprenorphine medicinal products to the schedule of products which can be prescribed for opioid substitution treatment.